Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Ossium Health, Inc.
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
University of Pittsburgh